Search
Main Menu
Main Content
Fermer
Choose language
FR
EN
Accessibility
Change contrast :
Standards
Reinforced
icone
HAS profile
Mission
Organisational Structure
Ethics, transparency and management of conflicts of interest
International relations and projects
Publications
English content
Medicines
Opinions on medical devices
INAHTA briefs
French website
Chercher
Recherche
icone plus
English content
Les recommandations et guides
Les médicaments
Les actes professionnels
Les dispositifs médicaux
Les médecins accrédités
Les articles d'information
Les établissements de santé
Chercher
My account
My account
Email alert Subscription
Newsletter Subscription
My search
Refresh
Please fill in your email address to retrieve your email alerts subscriptions.
New subscription
Please fill in your email address to retrieve your newsletter subscriptions.
You do not have a saved search
Mon Compte
Sélection
No element in selection
Favoris
Sélection
Établissements de santé
Contact
Abonnez-vous aux actualités
1 result
Topics : Cardiac arrhythmia
Topics : Economics and public health
Topics : Organisation of care
Active substance : apixaban
Active substance : disopyramide
Active substance : rivaroxaban
OK
Chercher
Filter
Topic
Economics and public health
(1)
Plus ...
Organisation of care
(1)
Diseases and conditions
(1)
Plus ...
Heart diseases
(1)
Plus ...
Cardiac arrhythmia
(1)
Content type
Practice Guidelines and Other Guides
(1)
Plus ...
Chronic disease guide
(1)
Date
Last five years
(1)
Language
Français
(1)
Active substance
apixaban
(1)
aspirine
(1)
cibenzoline
(1)
clopidogrel
(1)
disopyramide
(1)
rivaroxaban
(1)
More filter
Save your search
Search Export
Practice guidelines and other guides
- 1 result
Atrial fibrillation
Chronic disease guide
- Posted on 17/10/2023 - Mis à jour le 17/10/2023
Add to
my selection
Français
English
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
u1SUs4Lfr6NJ4b9G